BTIG Raises Mobia Medical Price Target to $20
The target implies substantial upside, though this is a single analyst opinion and no prior target was provided.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The target implies substantial upside, though this is a single analyst opinion and no prior target was provided.
What happened, with direct paths to the underlying reporting
BTIG raised its target for MOBI; the stated $20 target is well above the posted price of $11.28, indicating a bullish analyst view. Price had declined 0.8% since the signal.
Target: $20
Posted price: $11.28
Analyst firm: BTIG
Analyst: Ryan Zimmerman
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.